Factors affecting vancomycin-resistant Enterococcus faecium colonization of in-hospital patients in different wards
- PMID: 38406568
- PMCID: PMC10887344
- DOI: 10.4103/tcmj.tcmj_117_23
Factors affecting vancomycin-resistant Enterococcus faecium colonization of in-hospital patients in different wards
Abstract
Objectives: The prevalence of vancomycin-resistant Enterococcus faecium (VRE) infection at a medical center in Eastern Taiwan rose to 80.6%, exceeding the average prevalence of 55.6% among all medical centers nationwide during the same period. In recent years, the number of cases of VRE infection detected among hospitalized patients has increased annually. However, most of these patients in different wards are asymptomatic carriers. Therefore, restricting active screening to high-risk units will not improve the current situation, and it is necessary to review the risk factors for VRE colonization to provide a reference for future infection control policies.
Materials and methods: Between 2014 and 2019, there were 3188 VRE-positive cultures reported at our institution, as per the electronic medical records system.
Results: In the medical and surgical wards, patients who received penicillin (odds ratios [ORs]: 2.84 and 4.16, respectively) and third-generation cephalosporins (ORs: 3.17 and 6.19, respectively) were at higher risk of VRE colonization. In intensive care units, the use of carbapenems (OR: 2.08) was the most significant variable.
Conclusion: This study demonstrated that the risk factors for VRE colonization differed between wards. Thus, policies should be established according to the attributes of patients in each ward, and active screening tests should be performed according to individual risks, instead of a policy for comprehensive mass screening.
Keywords: Asymptomatic colonization; Colonization; Vancomycin-resistant Enterococcus.
Copyright: © 2023 Tzu Chi Medical Journal.
Conflict of interest statement
Dr. Tsung-Cheng Hsieh, an editorial board member at Tzu Chi Medical Journal, had no role in the peer review process of or decision to publish this article. The other authors declared no conflicts of interest in writing this paper.
Figures
Similar articles
-
[Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].Mikrobiyol Bul. 2011 Oct;45(4):646-54. Mikrobiyol Bul. 2011. PMID: 22090295 Turkish.
-
Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: a 2-year survey.Am J Infect Control. 1998 Dec;26(6):558-62. doi: 10.1053/ic.1998.v26.a86286. Am J Infect Control. 1998. PMID: 9836838
-
Is it worth screening for vancomycin-resistant Enterococcus faecium colonization?: Financial burden of screening in a developing country.Am J Infect Control. 2016 Apr 1;44(4):e45-9. doi: 10.1016/j.ajic.2015.11.008. Epub 2016 Jan 5. Am J Infect Control. 2016. PMID: 26775930
-
Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period.Arch Intern Med. 1999 Jul 12;159(13):1467-72. doi: 10.1001/archinte.159.13.1467. Arch Intern Med. 1999. PMID: 10399898
-
Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance.Am J Kidney Dis. 2015 Jan;65(1):88-97. doi: 10.1053/j.ajkd.2014.05.016. Epub 2014 Jul 17. Am J Kidney Dis. 2015. PMID: 25042816
Cited by
-
Vancomycin-Resistant Enterococci: Current Understandings of Resistance in Relation to Transmission and Preventive Strategies.Pathogens. 2024 Nov 5;13(11):966. doi: 10.3390/pathogens13110966. Pathogens. 2024. PMID: 39599519 Free PMC article. Review.
-
Unveiling the impact: COVID-19's influence on bacterial resistance in the Kingdom of Bahrain.World J Virol. 2025 Mar 25;14(1):100501. doi: 10.5501/wjv.v14.i1.100501. World J Virol. 2025. PMID: 40134836 Free PMC article.
References
-
- Tacconelli E, Cataldo MA. Vancomycin-resistant enterococci (VRE): Transmission and control. Int J Antimicrob Agents. 2008;31:99–106. - PubMed
-
- Reyes K, Bardossy AC, Zervos M. Vancomycin-resistant enterococci: Epidemiology, infection prevention, and control. Infect Dis Clin North Am. 2016;30:953–65. - PubMed
-
- Joshi S, Shallal A, Zervos M. Vancomycin-resistant enterococci: Epidemiology, infection prevention, and control. Infect Dis Clin North Am. 2021;35:953–68. - PubMed
-
- Centers for Disease Control and Prevention Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC) MMWR Recomm Rep. 1995;44:1–13. - PubMed
-
- Wang JT, Chang SC, Wang HY, Chen PC, Shiau YR, Lauderdale TL, et al. High rates of multidrug resistance in Enterococcus faecalis and E. faecium isolated from inpatients and outpatients in Taiwan. Diagn Microbiol Infect Dis. 2013;75:406–11. - PubMed
LinkOut - more resources
Full Text Sources